BestHealth4U’s Post

Have you ever wondered if it made more sense to upgrade your older technologies or innovate? Join us for a great discussion on January 18 hosted by our friends at MedAcuity, "Balanced Innovation: Navigating Legacy Technology Obsolescence and Innovation in Medtech." https://bit.ly/3v2GbQM Featuring experts from Insulet Corporation, #GTMHawthorne and MedAcuity, join the discussion to gain a comprehensive understanding of the factors to consider for achieving a balanced innovation strategy to meet evolving customer needs and stay ahead in a rapidly changing healthcare landscape. #medtech #innovation #healthtech #meddevice #legacy

🌟 We love being part of groundbreaking conversations! Our CFO, Eli Yered, took center stage as co-chair of the MedTech & Device Markets Panel: Innovation & Capital at the 11th Annual HealthTech Investment Forum, sharing insights on the future of MedTech and innovation in healthcare. The HealthTech Investment Forum is a key event that brings together leaders and innovators from across the healthcare and technology sectors. It’s where cutting-edge ideas meet capital, driving the advancements that shape the future of medical technology. Events like these are crucial for fostering collaboration and accelerating the next wave of healthcare innovation. 🎥 Catch the full session here: https://lnkd.in/dpkDYj7B — you don’t want to miss it! #MedTechInnovation #MedicalDevices #HealthTechInvesting #BiomedicalEngineering #DigitalHealth #HealthcareSolutions #Sachs_HTIF

𝐄𝐱𝐜𝐢𝐭𝐢𝐧𝐠 𝐁𝐫𝐞𝐚𝐤𝐭𝐡𝐫𝐨𝐮𝐠𝐡 𝐢𝐧 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 𝐓𝐞𝐜𝐡!🌟 Inspira Technologies, an Israeli startup revolutionizing life support, has unveiled remarkable advancements in its HYLA Blood Sensor! 🩸 💡 This innovative sensor, attached to life support tubes, continuously monitors blood oxygen and carbon dioxide pressures, providing precise insights into health disorders and patient well-being. 👏 What's truly groundbreaking? The HYLA achieves an impressive 95% accuracy compared to traditional blood gas analyzers, eliminating the need for invasive and intermittent blood tests. 🌐✨ 🔬 These results are propelling Inspira towards FDA approval, expected in the coming months! 🏥🚀 The HYLA, originally designed for INSPIRA ART, is making waves in healthcare with plans for a standalone variant in the works. 🌈 Join the healthcare revolution! Stay tuned for more updates on this game-changing technology. 🚀💊 Comment below if you're as excited as we are! 👇 https://lnkd.in/dBGt3v3r #HealthTechInnovation #InspiraTechnologies #HealthcareRevolution #MedicalAdvancements

🚀 Navigating Growth in the MedTech Sector at #Sachs_EHTF! Join us for the "Meeting the Challenges of Medtech & Device Growth Companies Panel" on February 27th, 2024, at the Hilton Zurich Airport Hotel. Unveil the strategies for overcoming hurdles and seizing opportunities in the rapidly evolving MedTech landscape. 🛠️💡 Chaired by: Cornelia Jahnel, Head Investor Relations, biosaxony Management GmbH Panellists: Andre Hofmann, CEO, biosaxony Management GmbH Matt Sagan, MBA, SVP, Chief Operating Officer, SDS Optic Inc. Sebastian Alexander, CEO, VivoSensMedical GmbH Steve Kappenthuler, Co-Founder & CBO, MUVON Therapeutics AG This session will delve into the complex challenges facing MedTech and medical device companies in their growth phase, including regulatory pathways, market access, and innovation scaling. Hear from seasoned industry leaders on how to successfully navigate these challenges, capitalize on technological advancements, and drive sustainable growth in a competitive market. Whether you are an emerging MedTech entrepreneur, an investor interested in the latest growth strategies, or a professional seeking to understand the future of medical technology, this panel is your opportunity to learn from the best in the business. Join us #inperson or #online to be at the forefront of MedTech innovation. Secure your spot now by registering at www.sachsforum.com/5ehtf. #EHTF2024 #HealthTech #DigitalHealth #MedTech #MedicalDevices #HealthcareInnovation #GrowthStrategies #MarketAccess #RegulatoryChallenges #InnovationInHealthcare #MedTechGrowth #MedicalTechnology #HealthcareSector #InvestinMedTech #SachsSpringLifeSciencesWeek #SSLSW

Musings from The MedTech Conference 2024 by AdvaMed The past 4 days have been nothing short of exhilarating! It is deeply inspiring being in a space full of people highly passionate about #MedTech, and equally passionate about improving #PatientOutcomes. — Here are three of my key takeaways: 1. #Innovation must not only exist within the #Product; but also in Business Models, Supply Chain, Clinical Workflows, and every other facet of the solution. One speaker challenged – “How do you wake up and #Innovate yourself every day?” 2. Current #GenAI is not targeted enough, innovators must identify exactly what problem they are trying to solve. This starts from the development teams – there must be an understanding of a targeted approach towards solving a specific problem. Is GenAI medically reasonable and medically required? 3. #SafetyByDesign and #SecureByDesign are key during the developmental phases. The principles of #RiskManagement must be present in the development workflow, and this takes discipline across all levels. Regulatory bodies are unable to regulate developmental activities, but will be strict during registration. — It’s been an immense pleasure meeting with old and new connections, and #Toronto is a breathtaking city! Looking forward to making more memories here before I return. Hui Ying Ang | Vanessa Ding | Jae Annie Tay | Genevieve Khoo | Dr Mayank Gurnani | Alfred Chia | Bo Zhang Fergal Kerins – PreOperative Performance | Kara LeBlanc – MedReddie | Tim Dutton – Intellijoint Surgical Inc. | Ricardo Celaya – Kolab Ventures | Arnoldo Heredia Astorga – GSE Biomedical

MedTech is led by the quality of products, emphasised Mr. Vikram Vuppala, Founder & CEO, NephroPlus, in our panel discussion on ‘Fostering Innovation, Manufacturing & Exports in the MedTech sector’. He stressed the importance of reputation in MedTech, requiring us to make solid products. #NATHEALTHAnnualSummit #AyushmanBharat #Connect #Collaborate #Create #IndianHealthcare #MedTech #PrivateHealthcare #DigitalHealth #HealthFinancing #CSRHealthcare #HealthcareExcellence #ArogyaBharatSummit

In the heart of Switzerland, amidst a dynamic ecosystem where startups and industry giants like Roche, Novartis, and Bayer converge, our journey in the medtech space, particularly in Software as a Medical Device (SaMD), is more than just business – it's a passion. With about 3,251 tech startups in Switzerland, a whopping 704 belong to the medtech and biotech sectors. Also, healthtech and life science host half of the Swiss Unicorns 🦄 💡In today’s medtech world, software isn't just an add-on; it's central to the functionality and innovation of medical devices. From user onboarding and data analysis to managing long-term health outcomes, the new-generation devices need high-performing apps. We've delved deep into the essence of SaMD, shedding light on what it truly entails and the complexities involved in creating such impactful solutions ✨ So, take a moment, grab a cup of coffee, and join us in exploring the intricacies of SaMD in our latest blog post. 🔗https://lnkd.in/dj326tEV #MedTech #SaMD #SwissInnovation #HealthcareTechnology #SoftwareDevelopment

AcuityMD Secures $45M Series B To Advance MedTech Platform Learn more & get our take 👇 https://lnkd.in/dCCxBUvh “AcuityMD’s innovative platform is reminiscent of other transformative, vertical-specific platforms that we have supported. We believe that there are also exciting opportunities to extend into other product areas and expand the value proposition, and ultimately for MedTech companies to use AcuityMD as their complete commercial operating system.” —Tengbo Li, Partner at ICONIQ Capital “I’m acutely aware of the unique challenges MedTech companies face when bringing products to market. AcuityMD has built an industry-specific platform that alleviates common pain points to help bring new treatments to patients faster. I am thrilled to be partnering with AcuityMD as it enters its next phase of growth.” — William A. Hawkins, former CEO at Medtronic “With this additional capital, we aim to launch three new products to general availability, expand our pipeline management solution to more customers, and grow our engineering and product teams by 70% by the end of 2024 to support our mission of accelerating the adoption of cutting-edge medical technology.” — Michael Monovoukas, CEO and co-founder at AcuityMD #funding #medtech #SoHCNews

Advance Mass Personalization for Healthcare Mass personalization is about delivering truly individual medicine. It has the potential to change the lives of millions of people around the world. The Mimics Innovation Awards celebrate those driving this shift and transforming healthcare. 🏥✨ Entering the Mimics Innovation Awards is simple and fast: just fill in a short form and upload your paper. Follow the link below to check out the rules and regulations and submit your research. #HealthcareInnovation #MassPersonalization #MimicsInnovationAwards #MedicalResearch #PersonalizedMedicine #academia #hospitals #biomedical